Daniel G Luca

Targets

• GBA1 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  Early-Onset Parkinson's Disease with 22q11.2 Microdeletion and Pathogenic GBA1 Variant.

  Movement disorders clinical practice, Aug 2026

• Publication

  Practice Patterns Related to Neuromodulation and Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa Infusion: A Survey of PSG Members.

  Movement disorders : official journal of the Movement Disorder Society, Aug 2026

• Publication

  A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism.

  Nature medicine, May 2026

• Publication

  Temporal trends and risk factors of hospital readmission following deep brain stimulation for Parkinson disease.

  Parkinsonism & related disorders, Jan 2026

• Publication

  Racial and Ethnic Diversity in Clinical Trials for Disease Modifying Drugs in Parkinson Disease: A Systematic Review & Meta-Analysis.

  Movement disorders clinical practice, Dec 2025

• Publication

  Revisiting the 2015 MDS diagnostic criteria for Parkinson disease: insights from autopsy-confirmed cases.

  NPJ Parkinson's disease, Dec 2025

Affiliations

• Washington University in St. Louis

Co-authors

• RBRoongroj BhidayasiriHow are we linked?

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.